SON and Global developmental delay: That same year, Tokita et al. (2016) described seven individuals between 3 and 23 years of age with de novo truncating variants in SON, two of them with the previously reported frameshift mutation, presenting with developmental delay, short stature, hypotonia, and congenital malformations in the brain, heart, lungs, kidneys, and gastrointestinal tract.